COVID-19: Information on ASPIRA LABS Operations

Click to Learn More
  • Home
  • Recent News and Upcoming Events

Recent News and Upcoming Events

Recent News


  • Vermillion Reports First Quarter 2020 Financial Results

    For a link to a pdf of the press release please click here AUSTIN, Texas — May 14, 2020 — Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the first quarter March 31, 2020. “Despite late first quarter challenges from COVID-19, we delivered strong…

  • Vermillion to Report First Quarter 2020 Financial Results on May 14

    For a pdf of the press release click here AUSTIN, Texas, April 30, 2020 – Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the first quarter ended March 31, 2020, on Thursday, May 14, 2020, after the market close, followed by…

  • Vermillion Inc. Announces ASPiRA LABS Now Credentialed as Florida State Medicaid Provider

    Fourth largest Medicaid population in the U.S. For a pdf of this press release click here AUSTIN, Texas, April 14, 2020 –Vermillion, Inc. (NASDAQ: VRML) today announced its wholly owned subsidiary, ASPiRA LABS, is now credentialed with Florida’s State Medicaid program for an estimated additional 3.6 million credentialed Medicaid lives. Florida has the fourth largest state…

  • Vermillion Announces Cigna Preferred Contract Coverage for OVA1, OVERA and Genetics Testing

    For a pdf of this press release click here AUSTIN, Texas, March 27, 2020 – Vermillion, Inc. (NASDAQ: VRML), a bioinformatics-based women’s health company focused on gynecologic disease, announced yesterday that its wholly owned subsidiary, ASPiRA Labs, has signed a national preferred agreement with Cigna. This contract includes OVA1, (Multivariate Index Assay, MIA) our ACOG endorsed…

  • Vermillion Reports Fourth Quarter 2019 Financial Results

    For a pdf of this press release please click here Click Here for Earnings Supplement AUSTIN, Texas — March 26, 2020 — Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the fourth quarter and year ended December 31, 2019. “We are very pleased with…

Upcoming Events


  • March 15–17, 2020

    Laguna Niguel, CA

    32nd Annual Roth Conference

  • March 28–31, 2020

    Toronto, Canada

    Society of Gynecologic Oncology Annual Meeting

  • March 28 - April 3

    La Jolla, CA

    ACOOG 87th Annual Conference

  • April 24–27, 2020

    Seattle, WA

    American College of Obstetricians and Gynecologists Annual Meeting

Investor Relations


  • Ashley R. Robinson

    LifeSci Advisors, LLC

    617-535-7742